it will be the first approved treatment for Alagille syndrome. The therapy is currently being evaluated in late-stage clinical studies in other rare cholestatic liver diseases & has received BTD for ALGS and PFIC type 2 and ODD for ALGS
Mirum’s Livmarli (maralixibat) Receives EMA’s CHMP Positive Opinion for Cholestatic Pruritus in Patients with Alagille Syndrome
October 17, 2022
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.